source
- Scribe Therapeutics launches $129M IPO, kicking off second-half biotech listing spreeScribe Therapeutics, a nine-year-old biotech co-founded by CRISPR pioneer Jennifer Doudna, announced its initial public offering. The company priced the IPO at about $128.7 million, raising roughl…
- FDA advisory panel recommends adding peptides BPC-157 and KPV to bulk compounding listAn FDA advisory committee voted 8-6, with one abstention, to recommend that two experimental peptides – BPC-157 for ulcerative colitis and KPV for wound and inflammatory conditions – be placed on t…